Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular Pharmacology

• Publication date

  2005-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.104.008615PMID 15692146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting

  2004cited by this paper
• Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes*

  2004influential reference
• The pharmacology of CGRP-responsive receptors in cultured and transfected cells.

  2004cited by this paper
• Novel fish-derived adrenomedullin in mammals: structure and possible function.

  2004influential reference
• Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor*

  2004cited by this paper
• Vascular actions of calcitonin gene-related peptide and adrenomedullin.

  2004cited by this paper
• Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins.

  2004cited by this paper
• Novel Receptor Partners and Function of Receptor Activity-modifying Proteins*

  2003cited by this paper
• CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and BIBN4096BS

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Calcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family

  2003influential reference
• International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

  2002cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.

  2001cited by this paper
• Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.

  2001cited by this paper
• Vascular Abnormalities and Elevated Blood Pressure in Mice Lacking Adrenomedullin Gene

  2001cited by this paper
• Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.

  2000cited by this paper
• Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition.

  2000cited by this paper
• Adrenomedullin, a multifunctional regulatory peptide.

  2000cited by this paper
• Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product.

  2000cited by this paper
• Qualitative and quantitative assessment of relative agonist efficacy.

  1999cited by this paper
• Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.

  1999cited by this paper
• Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.

  1999cited by this paper
• Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor.

  1999cited by this paper
• An Amylin Receptor Is Revealed Following Co-Transfection of a Calcitonin Receptor with Receptor Activity Modifying Proteins-1 or -3.

  1999cited by this paper
• An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.

  1999cited by this paper
• Assessing the distribution of parameters in models of ligand-receptor interaction: to log or not to log.

  1998cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998cited by this paper
• The selectivity and structural determinants of peptide antagonists at the CGRP receptor of rat, L6 myocytes

  1997cited by this paper
• Differential Calcitonin Gene‐Related Peptide (CGRP) and Amylin Binding Sites in Nucleus Accumbens and Lung: Potential Models for Studying CGRP/Amylin Receptor Subtypes

  1995cited by this paper
• Binding sites for islet amyloid polypeptide in mammalian lung: species variation and effects on adenylyl cyclase.

  1995cited by this paper
• Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease.

  1994cited by this paper
• Cloning and characterization of an abundant subtype of the human calcitonin receptor.

  1994cited by this paper
• Influence of Islet Amyloid Polypeptide and the 8–37 Fragment of Islet Amyloid Polypeptide on Insulin Release From Perifused Rat Islets

  1993cited by this paper
• Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences.

  1991cited by this paper
• Expression cloning of an adenylate cyclase-coupled calcitonin receptor.

  1991cited by this paper
• hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.

  1990cited by this paper
• A Pharmacologic Analysis of Drug-Receptor Interaction

  1987cited by this paper
• Properties of a calcitonin receptor and adenylate cyclase in BEN cells, a human cancer cell line.

  1980cited by this paper

• Emerging incretin- and multi-agonist-based treatments - the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond.

  2026cites this paper
• The story of amylin: from physiology to therapy

  2026cites this paper
• Extracellular ATP increases agonist potency and reduces latency at class B G protein-coupled receptors

  2025cites this paper
• Supramolecular oral delivery technologies for polypeptide-based drugs.

  2025cites this paper
• The (dys)regulation of energy storage in obesity.

  2025cites this paper
• Calcitonin receptors in GtoPdb v.2025.3

  2025cites this paper
• Role of amylin in feeding and satiation.

  2025cites this paper
• Amylin and the amylin receptors in migraine: Is there another pathway to target?

  2025cites this paper
• Pharmacological characterization of ubrogepant and atogepant in cAMP assays at human, rat, and mouse calcitonin family receptors in transfected cells.

  2025cites this paper
• Molecular Anatomy of Synaptic and Extrasynaptic Neurotransmission Between Nociceptive Primary Afferents and Spinal Dorsal Horn Neurons

  2025cites this paper
• Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment.

  2025cites this paper
• RAMP1 Signaling Mitigates Acute Lung Injury by Distinctively Regulating Alveolar and Monocyte-Derived Macrophages

  2024cites this paper
• Delineating the impact of N21D mutation on the conformational preferences and structural transitions in human islet amyloid polypeptide

  2024cites this paper
• Variable CGRP family peptide signaling durations and the structural determinants thereof.

  2024cites this paper
• Cryo-EM Structure of the Human Amylin 1 Receptor in Complex with CGRP and Gs Protein

  2024cites this paper
• TSPO in pancreatic beta cells and its possible involvement in type 2 diabetes.

  2024cites this paper
• Lack of RAMP1 Signaling Suppresses Liver Regeneration and Angiogenesis Following Partial Hepatectomy in Mice

  2024influential citation
• Functional Analysis and Tissue-Specific Expression of Calcitonin and CGRP with RAMP-Modulated Receptors CTR and CLR in Chickens

  2024cites this paper
• Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene‐related peptide responsive receptors

  2023cites this paper
• Chronic salmon calcitonin exerts an antidepressant effect via modulating the p38 MAPK signaling pathway

  2023influential citation
• Islet amyloid polypeptide does not suppress pancreatic cancer

  2023cites this paper
• Deletion of RAMP1 Signaling Enhances Diet-induced Obesity and Fat Absorption via Intestinal Lacteals in Mice

  2023cites this paper
• A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene‐related peptide and beyond

  2022cites this paper
• Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor

  2022cites this paper
• Creating the amylin story.

  2022cites this paper
• New Insights into the Structure and Function of Class B1 GPCRs

  2022cites this paper
• A structural basis for amylin receptor phenotype

  2022cites this paper
• Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors

  2022cites this paper
• Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins

  2022cites this paper
• Amylin and calcitonin - physiology and pharmacology.

  2022cites this paper
• CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

  2022cites this paper
• Mediators of Amylin Action in Metabolic Control

  2022influential citation
• Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors.

  2022cites this paper
• AM833 Is a Novel Agonist of Calcitonin Family G Protein–Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists

  2021cites this paper
• Pharmacological characterisation of mouse calcitonin and calcitonin receptor‐like receptors reveals differences compared with human receptors

  2021cites this paper
• Poly(ADP-Ribose) Polymerase Inhibitors for Arsenic Trioxide–Resistant Acute Promyelocytic Leukemia: Synergistic In Vitro Antitumor Effects with Hypomethylating Agents or High-Dose Vitamin C

  2021cites this paper
• The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice.

  2021cites this paper
• Migraine therapeutics differentially modulate the CGRP pathway

  2021cites this paper
• CGRP receptor antagonists for migraine. Are they also AMY1 receptor antagonists?

  2021cites this paper
• Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors

  2021cites this paper
• Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer’s Disease Mouse Models

  2021cites this paper
• Response to letter to the Editor: Assessing migraine therapeutics

  2021cites this paper
• Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

  2021cites this paper
• Calcitonin receptors in GtoPdb v.2021.2

  2021cites this paper
• Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors

  2020cites this paper
• Viral depletion of calcitonin receptors in the area postrema: A proof-of-concept study.

  2020cites this paper
• Adrenomedullin - Current Perspective on a Peptide Hormone with Significant Therapeutic Potential.

  2020cites this paper
• RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.

  2020cites this paper
• Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases.

  2020cites this paper
• Molecular interaction of an antagonistic amylin analog with the extracellular domain of receptor activity-modifying protein 2 assessed by fluorescence polarization.

  2020cites this paper
• Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia

  2020cites this paper
• Asn‐linked N–acetylglucosamine of the amylin receptor 2 extracellular domain enhances peptide ligand affinity

  2020cites this paper
• RAMP1 signaling in immune cells regulates inflammation-associated lymphangiogenesis

  2020cites this paper
• Analysis of Amylin Consensus Sequences Suggests that Human Amylin is Not Optimized to Minimize Amyloid Formation and Provides Clues to Factors that Modulate Amyloidogenicity.

  2020cites this paper
• Inhibition of receptor activity–modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vessels

  2020cites this paper
• Galcanezumab for the prevention of cluster headache

  2020cites this paper
• Anti-CGRP in cluster headache therapy

  2019cites this paper
• The neuropeptide receptor subunit RAMP1 constrains the innate immune response during acute pancreatitis in mice.

  2019cites this paper
• Role of amylin and calcitonin-gene related peptide (CGRP) in the control of eating

  2019cites this paper
• A contemporary biological pathway of islet amyloid polypeptide for the management of diabetic dementia.

  2019cites this paper
• Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model

  2019cites this paper
• Pharmacological characterization and investigation of N-terminal loop amino acids of adrenomedullin 2 that are important for receptor activation.

  2019cites this paper
• Calcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• An amylin analogue attenuates alcohol-related behaviours in various animal models of alcohol use disorder

  2019cites this paper
• RAMP1 and RAMP3 differentially control amylin's effects on food intake, glucose and energy balance in male and female mice.

  2019influential citation
• Deconvoluting the Molecular Control of Binding and Signaling at the Amylin 3 Receptor: RAMP3 Alters Signal Propagation through Extracellular Loops of the Calcitonin Receptor.

  2019cites this paper
• Molecular studies of CGRP and the CGRP family of peptides in the central nervous system

  2019cites this paper
• Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25

  2018cites this paper
• Synthesis of N-Linked Glycopeptides Using Convergent Enzymatic Glycosylation Combined with SPPS

  2018cites this paper
• CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured

  2018cites this paper
• Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases

  2018influential citation
• CGRP Receptor Biology: Is There More Than One Receptor?

  2018cites this paper
• Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin.

  2018cites this paper
• Amyloidogenicity, Cytotoxicity, and Receptor Activity of Bovine Amylin: Implications for Xenobiotic Transplantation and the Design of Nontoxic Amylin Variants.

  2018cites this paper
• Current understanding of the structure and function of family B GPCRs to design novel drugs

  2018cites this paper
• Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX

  2018cites this paper
• Dual Amylin and Calcitonin Receptor Agonists: A Novel Treatment for Obesity and Related Co-Morbidities

  2017cites this paper
• Amylin and Leptin: Co-Regulators of Energy Homeostasis and Neuronal Development.

  2017cites this paper
• Running Title : CGRP receptor in global human RAMP 1 mice

  2017cites this paper
• Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity

  2017cites this paper
• CGRP family of peptides : IUPHAR Review : ” X ” Running title : Pharmacology of the calcitonin / CGRP family

  2017cites this paper
• RAMP1 suppresses mucosal injury from dextran sodium sulfate‐induced colitis in mice

  2017cites this paper
• Human-derived antibody targeting pancreatic islet amyloid for the treatment of type 2 diabetes

  2017cites this paper
• Molecular determinants of amylin receptor agonism

  2017influential citation
• CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1

  2017cites this paper
• Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca2+ levels in the perfused and non-perfused isolated rat middle cerebral artery

  2017cites this paper
• Family B G Protein-coupled Receptors and their Ligands: From Structure to Function.

  2017cites this paper
• Amylin

  2017cites this paper
• Class B GPCR: Receptors and RAMPs

  2017cites this paper
• RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice.

  2017cites this paper
• CGRP and its receptors

  2017cites this paper
• Leptin influences the excitability of area postrema neurons.

  2016cites this paper
• Human Islet Amyloid Polypeptide N-Terminus Fragment Self-Assembly: Effect of Conserved Disulfide Bond on Aggregation Propensity

  2016cites this paper
• An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

  2016cites this paper
• Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells.

  2016cites this paper
• Chapter 58 – Calcitonin

  2016cites this paper
• Mapping the calcitonin receptor in human brain stem.

  2016cites this paper
• Calcitonin and Amylin Receptor Peptide Interaction Mechanisms

  2016cites this paper
• Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

  2016cites this paper
• Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

  2016cites this paper